FDA Approves Roche, Curis Skin-Cancer Drug

Loading...
Loading...
Roche and Curis' drug is the first approved therapy for advanced basal cell carcinoma.
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...